FDA Brief

Company record

Namita A. Goyal, M.D.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Namita A. Goyal, M.D..

Warning letters

  1. Namita A. Goyal, M.D.

    FDA warned clinical investigator Dr. Namita Goyal over a biologic trial that enrolled ineligible subjects and kept poor records.

    High risk